Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

HIV/AIDS

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge
 

Tenofovir and HBV Prophylaxis

for Health Care Providers

Tenofovir-Containing ART as HBV Prophylaxis

We all have patients who just don't get a sAb response to hepatitis B (HBV) vaccination even with repeat vaccination or higher-dose vaccine. A recent retrospective look at rates of incident HBV infection in a cohort of HIV-positive men who have sex with men who were on ART indicates that tenofovir may function as prophylaxis. It found that use of tenofovir as part of the ART regimen was associated with a sharply lower rate of HBV infection (0.14 infections/100 patient-years vs 2.85 if the ART included no HBV-active drugs, and 1.36 if 3TC was the only HBV-active drug in the regimen). Further data will be needed to support this finding, but these results appear quite promising.

Reference

Heuft MM, Houba SM, van den Berk GE, et al. Protective effect of hepatitis B virus-active antiretroviral therapy against primary hepatitis B virus infection. AIDS. 2014 Apr 24;28(7):999-1005.